Pharmaceutical - Markets & Marketing, Patents

Filter

Popular Filters

1 to 25 of 45 results

Joint position to grow Australia's biopharmaceutical industry

Joint position to grow Australia's biopharmaceutical industry

29-05-2014

Trade groups AusBiotech and Medicines Australia this morning published a joint statement sent to the…

AustraliaBiotechnologyFinancialMarkets & MarketingPatentsPharmaceuticalResearch

Pharma MNCs developing new pricing and market access strategies for India

01-05-2014

New research suggest that certain multinational pharmaceutical companies (MNCs) are experimenting with…

IndiaMarkets & MarketingPatentsPharmaceuticalPricing

Rapid growth for Indonesian pharma market, but weak IP enforcement poses threat

Rapid growth for Indonesian pharma market, but weak IP enforcement poses threat

01-05-2014

Driven by increased government health care spending and growing life expectancy, the Indonesian pharmaceutical…

IndonesiaMarkets & MarketingPatentsPharmaceutical

Vietnam's pharma market among the fastest growing in Southeast Asia

22-04-2014

Vietnam is currently one of the fastest growing pharmaceutical markets in Southeast Asia, recording a…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalPricing

India’s patents moves could see particular uncertainty for diabetes sector

India’s patents moves could see particular uncertainty for diabetes sector

17-02-2014

The Indian government's decision to review patented drugs by multinationals, to allow for the manufacture…

Abbott LaboratoriesAsia-PacificDiabetesEli LillyIndiaMarkets & MarketingMerck & CoNovo NordiskPatentsPharmaceutical

Patent expiries will push Parkinson’s drug market lower by 2019

17-12-2013

Due to upcoming patent expirations for four high-profile drugs, the global Parkinson’s disease (PD)…

GlobalImpax LaboratoriesMarkets & MarketingNeurologicalNewron PharmaPatentsPharmaceuticalpimavanserinRytarysafinamide

Indian pharmaceutical market to reach $56 billion by 2020, says GlobalData

03-10-2013

Driven by the country’s growing economy and population income, the Indian pharmaceutical market will…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalRegulation

Analyst's view on Irish pharma export woes

29-07-2013

Following the news that Ireland's pharmaceutical industry has experienced a sharp fall in exports due…

EuropeMarkets & MarketingPatentsPharmaceuticalProduction

Enhanced IP protection for medicines will help Canada with trade agreements, says think-tank

16-07-2013

Canada's protection of intellectual property (IP) in the pharmaceutical industry falls short of international…

Markets & MarketingNorth AmericaPatentsPharmaceutical

Market access barriers for multinationals, but Argentina still offers attractive pharma opportunities

31-05-2013

Several barriers impede market access but the regulatory landscape in Argentina is changing and attractive…

BiotechnologyMarkets & MarketingPatentsPharmaceuticalRegulationSouth America

Government health care reforms foster development China's Pharma market, says F&S

28-05-2013

Rising incomes, improving health care infrastructure and enhanced insurance systems have propelled the…

Asia-PacificGenericsHealthcareMarkets & MarketingPatentsPharmaceuticalPolitics

CML drug revenue in Japan to grow, despite global decline, says GlobalData

21-05-2013

Bucking a global trend of falling revenues, weak penetration of generic drugs and an increasing patient…

Asia-PacificBristol-Myers SquibbGleevecMarkets & MarketingNovartisOncologyPatentsPharmaceuticalSprycel

Neurodegenerative diseases market to survive patent cliff, due to new therapeutics

15-05-2013

New market entrants are set to defend the neurodegenerative diseases market from the looming patent cliff,…

Markets & MarketingNeurologicalPatentsPharmaceutical

Argentina's pharma market to almost triple over one decade, says GlobalData

24-04-2013

Argentina's pharmaceutical market is expected to grow from a value of around $5.6 billion in 2012 to…

GenericsMarkets & MarketingPatentsPharmaceuticalProductionRegulationSouth America

Portugal debt crisis strangling pharma sector growth

21-04-2013

The Portuguese pharmaceutical market has struggled in recent years, and new government policies restraining…

EuropeGenericsMarkets & MarketingPatentsPharmaceuticalPricing

Analysis of China government incentives for pharma

27-03-2013

China remains an attractive target for pharmaceutical research and manufacturing, and major players from…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPatentsPharmaceutical

Thailand flouts pharmaceutical patent protection; report

08-03-2013

Lax enforcement of patent regulations in Thailand is alienating American intellectual property laws,…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceutical

EU Commission sends antitrust complaint to Johnson & Johnson and Novartis

01-02-2013

The European Commission has informed US health care giant Johnson & Johnson (NYSE: JNJ) and Swiss drug…

DuragesicEuropefentanylGenericsJanssen-CilagJohnson & JohnsonLegalMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalSandoz

European Commission enforcement action in pharmaceutical sector following sector inquiry

31-01-2013

Following its competition inquiry into the pharmaceutical sector of 2008/2009, the European Commission…

DuragesicEuropeGenericsJohnson & JohnsonLundbeckMarkets & MarketingPatentsPharmaceuticalServier

Patent cliff: one drugmaker's sorrow is another one's joy

20-01-2013

The patent cliff has seen many drug majors lose their exclusivity on blockbuster drugs to generic makers…

DilantinGenericsLystedaMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsPharmaceuticalWatson Pharmaceuticals

European Alzheimer's drug market to grow to $4.78 billion by 2019, says F&S

25-11-2012

The patent expiry of all four existing European Medicines Agency-approved drugs for Alzheimer's disease…

AriceptEbixaEisaiEuropeExelon PatchLundbeckMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalResearch

Saudi Arabia aims to improve national health care with patent and drug approval changes

11-11-2012

Saudi Arabia is taking back control of its health care industry, states a new report by the business…

GenericsHealthcareMarkets & MarketingPatentsPharmaceuticalRegulationRest of the World

EFPIA welcomes Commission policy strategy agenda to strengthen Pharma competitiveness

12-10-2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the European Commission…

BiotechnologyEuropeMarkets & MarketingPatentsPharmaceuticalPoliticsPricing

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

1 to 25 of 45 results

Back to top